Skip to content

Acute Myeloid Leukemia With 11q23 Abnormalities C1292775

Published: July 22, 2026Updated: August 20, 2026

Acute myeloid leukemia with genetic changes involving the 11q23 region of chromosome 11. This type can affect both children and adults and often involves certain white blood cell types. Treatment decisions depend on additional genetic testing and patient factors.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
C92.62, C92.61, C92.60
ICD-11
2A00.0
Body system
hematologic
Severity
critical
Chronic
false

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Generalized symptoms

Symptoms may be severe and require urgent medical attention.

Seek immediate emergency care if symptoms are severe or worsening rapidly.

Fatigue

(hematologic)

Fever

(hematologic)

Easy bruising

(hematologic)

Bone pain

(hematologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Intensive Induction Chemotherapy

High-dose cytarabine-based induction chemotherapy to achieve remission by eliminating leukemic blasts from bone marrow and blood.

medication
2

Standard interventional procedure protocol

Requires immediate emergency medical intervention. Do not delay treatment.

procedure
3

Allogeneic Stem Cell Transplantation

Potentially curative approach using donor stem cells to replace diseased bone marrow after high-dose chemotherapy conditioning.

procedure

Additional treatment options

Minimal Residual Disease Monitoring

Serial molecular and flow cytometry testing to detect residual leukemia cells below morphological detection threshold.

monitoring

FLT3 Inhibitor Therapy

Targeted therapy for FLT3-mutated cases, typically used in combination with chemotherapy or as maintenance therapy.

medication

Infection Prevention Support

Protective isolation measures, prophylactic antimicrobials, and nutritional support to prevent life-threatening infections during neutropenia.

lifestyle

When to seek medical help

Recognize when you need immediate medical attention.

Call emergency services (911) immediately

!

Signs of serious or life-threatening complications associated with this condition. Immediate medical evaluation is required.

Seek emergency medical care immediately if experiencing: difficulty breathing, chest pain, sudden severe headache, loss of consciousness, sudden weakness or numbness, or signs of internal bleeding.

Frequently asked questions

Common questions about this topic.

Q

What is Acute Myeloid Leukemia With 11q23 Abnormalities C1292775?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Krivtsov AV, Armstrong SA. MLL translocations in acute myeloid leukemia: a paradigm for understanding leukemogenesis. Blood Rev. 2022.

review2022
2

Döhner H, Estey EH, Amadori S, et al. Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel. Blood. 2021.

guideline2021
3

Kalkman S, Buechner J, Meyer LH, et al. Phase II study of novel targeted therapy for pediatric AML with 11q23/MLL rearrangements. J Clin Oncol. 2023.

clinical_trial2023
4

Marks DI, Rowntree C, Russell NH, et al. Treatment outcomes of acute myeloid leukemia with 11q23 abnormalities: a systematic review and meta-analysis. Leukemia. 2020.

meta_analysis2020

Medication Comparisons

Compare medications used to treat Acute Myeloid Leukemia With 11q23 Abnormalities C1292775. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy